PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
877.13%
Revenue growth above 1.5x OGI.TO's 193.64%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
177.09%
Gross profit growth above 1.5x OGI.TO's 10.48%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-20.78%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-20.78%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
83.07%
Positive net income growth while OGI.TO is negative. John Neff might see a big relative performance advantage.
83.25%
Positive EPS growth while OGI.TO is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
83.25%
Positive diluted EPS growth while OGI.TO is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.59%
Share reduction more than 1.5x OGI.TO's 300.76%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.59%
Diluted share reduction more than 1.5x OGI.TO's 300.76%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
54.66%
Positive OCF growth while OGI.TO is negative. John Neff would see this as a clear operational advantage vs. the competitor.
39.94%
FCF growth above 1.5x OGI.TO's 4.83%. David Dodd would verify if the firm’s strategic investments yield superior returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1466.81%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-1466.81%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-1466.81%
Negative 3Y OCF/share CAGR while OGI.TO stands at 45.55%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-86.27%
Negative 10Y net income/share CAGR while OGI.TO is at 117.36%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-86.27%
Negative 5Y net income/share CAGR while OGI.TO is 117.36%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-86.27%
Negative 3Y CAGR while OGI.TO is 103.65%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
147.79%
Equity/share CAGR of 147.79% while OGI.TO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
147.79%
Equity/share CAGR of 147.79% while OGI.TO is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
147.79%
Positive short-term equity growth while OGI.TO is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.22%
AR growth is negative/stable vs. OGI.TO's 730.74%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
92.35%
Inventory growth well above OGI.TO's 36.98%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.72%
Negative asset growth while OGI.TO invests at 17.11%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.67%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-68.21%
We cut SG&A while OGI.TO invests at 23.91%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.